• Eight pharmacists from SEHA-affiliated Sheikh Khalifa Medical City (SKMC) and Tawam Hospital have been selected to join the first cohort of the residency program 

Abu Dhabi: Abu Dhabi Health Services Company (SEHA), the largest healthcare network in the UAE, is bridging the gap between university medical qualification and clinical professional practices with its Pharmacy Residency Program – the country’s first and only training initiative accredited by the American Society of Health-System Pharmacists (ASHP). The two-year program has been specially designed to advance the practice of post-graduate pharmacists, providing them with experiential learning and on-the-job exposure to pharmaceutical care in various hospital settings.

SEHA has selected eight pharmacists to join the first cohort from its affiliated centers in Sheikh Khalifa Medical City (SKMC) and Tawam Hospital, empowering them to benefit from opportunities to accelerate their growth beyond entry-level professional competence. Upon successful completion, graduates will be able to advance their careers in pharmacy operational services, or build stronger credentials through advanced training programs, specialized residencies, or fellowships.

Dr. Anwar Sallam, Group Chief Medical Officer, SEHA, said: “As we continuously adapt to meet the ongoing demands of an ever-evolving healthcare landscape, we are always on the lookout for new and promising talent to drive us forward. SEHA’s Pharmacy Residency Program provides us with young, knowledgeable, and eager professionals with novel and innovative ideas who have the opportunity to refine our pharmaceutical offerings and services. By giving the residents access to a collaborative and nurturing environment, we are opening doors for them to integrate into the real world and gain valuable on-the-job experience that will shape their careers in the years to come.”

Program residents will be trained and evaluated under the continuous preceptorship of SEHA’s industry leading, multi-disciplinary healthcare consultants, with modules encompassing acute and ambulatory care, drug use policy development, clinical services and pharmacy leadership, as well as research across a diverse range of integrated healthcare systems and practice-based experiences. Residents will also be able to improve their overall clinical knowledge, critical thinking, and self-evaluation skills and develop crucial leadership skills that can be applied in any position across any practice setting.

Dr. Waiel Al Naeem, Director of SEHA Pharmacy Residency Program, noted that the launch marks a stellar opportunity for the future leaders of the UAE’s pharmaceutical industry. “The SEHA Pharmacy Residency Program is testament to SEHA’s commitment to elevate the provision of world-class healthcare services to the people of the UAE. The first-of-its-kind, and pioneering, academic training program in the country is on par with international best practices, enabling our nation’s healthcare professionals to not only gain necessary experience but also develop critical thinking skills to move forward and achieve success in the ever-changing world of pharmacy practice.”

Successful graduates of the SEHA Pharmacy Residency Program are evaluated against six outcome measures: managing and improving the medication-use process; providing evidence-based, patient-centered medication therapy management with interdisciplinary teams; implementing leadership and practice management skills; demonstrating project management skills; providing medication and practice-related education/training; and utilizing medical informatics.

-Ends-

About SEHA:

The Abu Dhabi Health Services Company PJSC–SEHA – is an independent, public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi.

SEHA is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.

SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class healthcare. SEHA operates 13 hospitals with 3,385 beds, 70 ambulatory care, family care and urgent care centers and 2 blood banks. Its facilities accommodate 117,162 inpatients annually and conduct 43,262 surgeries, as well as treating more than five million outpatients. SEHA is one of the largest integrated healthcare providers in the Middle East with more than 18,000 doctors, nurses, ancillary care, and administrative personnel. Learn more at www.seha.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.